Skip to content

Vitreous Fragments Length After Pars Plana Vitrectomy

Vitreous Fragments Length After Pars Plana Vitrectomy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04570007
Enrollment
25
Registered
2020-09-30
Start date
2020-09-20
Completion date
2021-12-10
Last updated
2021-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitreous Anomalies, Vitreous Disorder

Brief summary

To measure vitreous collagen fragments length after pars plana vitrectomy performed at different cut rates

Detailed description

Pars plana vitrectomy consists in the removal of vitreous obtained with a vitreous cutter. The instruments attracts vitreous in its port through active suction and cuts with a blade at different cut rates. There is no consensus as to which cut rate would be ideal in order to minimize traction, neither there is agreement on whether increasing cut rates generate shorter collagen fragments or the fluid turbulence creates unpredictable flows at the port generating fragments of different length. The investigators plan to gather vitreous cut at 1,000, 2,000, 4,000, 8,000 and 16,000 cuts per minute and measure vitreous collagen average length

Interventions

PROCEDUREPars Plana Vitrectomy

removal of vitreous with vitreous cutter

Sponsors

Ospedale Policlinico San Martino
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

* patient undergoing pars plana vitrectomy for: * macular pucker * macular hole- * retinal detachment * age \>18

Exclusion criteria

* unwilling to participate * previous trauma * vitreous haemorrhage

Design outcomes

Primary

MeasureTime frameDescription
collagen fragment molecular weigthat time of surgerycollagen passed through the vitreous cutter is examined with regard to collagen moecular weigth

Countries

Italy

Contacts

Primary ContactTommaso Rossi
tommaso.rossi024@gmail.com+393482645034

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026